糖萼降解与重症及致死性恶性疟疾相关
该前瞻性研究纳入129例印尼成人住院患者(重症疟疾43例、中重症57例、健康对照29例),检测尿糖萼降解产物(GAG-DMMB与GAG-MS)并评估血管一氧化氮生物利用度。结果显示重症患者糖萼降解产物显著高于中重症和健康对照(P<0.001),且重症患者中死亡者降解产物高于存活者(P=0.03),糖萼降解与寄生虫生物量正相关、与内皮NO生物利用度负相关。
要点
- 重症恶性疟疾成人患者尿糖萼降解产物显著升高。
- 糖萼降解程度与致死结局及寄生虫生物量相关。
- 糖萼降解与内皮NO生物利用度呈负相关。
核心结论
- 内皮糖萼降解增加与成人恶性疟疾重症及致死结局相关。
研究设计与样本
- 前瞻性队列研究,纳入129例印尼成人住院患者(重症43例、中重症57例、健康对照29例),按WHO标准分组。
主要发现
- 重症患者GAG-DMMB均值3.98(95%CI 2.44-5.53)、GAG-MS均值6.82(95%CI 5.19-8.44),高于中重症(1.78,95%CI 1.27-2.29;4.87,95%CI 4.27-5.46)和健康对照(0.22,95%CI 0.06-0.37;1.24,95%CI 0.89-1.59),P<0.001。
- 重症患者中死亡者(n=3)GAG-DMMB中位数6.72(IQR 3.80-27.87)、GAG-MS中位数12.15(IQR 7.88-17.20),高于存活者(n=39;3.10,IQR 0.46-4.5;4.64,IQR 2.02-15.20),P=0.03。
- 糖萼降解与寄生虫生物量正相关:中重症r=0.48(GAG-DMMB)和r=0.43(GAG-MS),P<0.001;重症r=0.47(P=0.002)和r=0.33(P=0.04)。
- 糖萼降解与内皮NO生物利用度呈负相关。
临床怎么用
- 尿糖萼降解产物或可作为成人恶性疟疾病情严重程度及死亡风险的辅助评估指标。
局限性
- 死亡病例数较少(n=3),需更大样本验证。
- 研究仅纳入印尼成人住院患者,外推需谨慎。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Interactions between the endothelium and infected erythrocytes play a major role in the pathogenesis of falciparum malaria, with microvascular dysfunction and parasite sequestration associated with worsening outcomes. The glycocalyx is a carbohydrate-rich layer that lines the endothelium, with multiple roles in vascular homeostasis. The role of the glycocalyx in falciparum malaria and the association with disease severity has not been investigated. METHODS: We prospectively enrolled Indonesian inpatients (aged ≥18 years) with severe (SM) or moderately severe (MSM) falciparum malaria, as defined by World Health Organization criteria, and healthy controls (HCs). On enrollment, blood and urine samples were collected concurrently with measurements of vascular nitric oxide (NO) bioavailability. Urine was assayed for glycocalyx breakdown products (glycosaminoglycans) using a dimethylmethylene blue (GAG-DMMB) and liquid chromatography-tandem mass spectrometry (GAG-MS) assay. RESULTS: A total of 129 patients (SM = 43, MSM = 57, HC=29) were recruited. GAG-DMMB and GAG-MS (g/mol creatinine) were increased in SM (mean, 95% confidence interval: 3.98, 2.44-5.53 and 6.82, 5.19-8.44) compared to MSM patients (1.78, 1.27-2.29 and 4.87, 4.27-5.46) and HCs (0.22, 0.06-0.37 and 1.24, 0.89-1.59; P < 0.001). In SM patients, GAG-DMMB and GAG-MS were increased in those with a fatal outcome (n = 3; median, interquartile range: 6.72, 3.80-27.87 and 12.15, 7.88-17.20) compared to survivors (n = 39; 3.10, 0.46-4.5 and 4.64, 2.02-15.20; P = 0.03). Glycocalyx degradation was significantly associated with parasite biomass in both MSM (r = 0.48, GAG-DMMB and r = 0.43, GAG-MS; P < 0.001) and SM patients (r = 0.47, P = 0.002 and r = 0.33, P = 0.04) and inversely associated with endothelial NO bioavailability. CONCLUSIONS: Increased endothelial glycocalyx breakdown is associated with severe disease and a fatal outcome in adults with falciparum malaria.
引用
- Yeo TW, Weinberg JB, Lampah DA, et al. Glycocalyx Breakdown Is Associated With Severe Disease and Fatal Outcome in Plasmodium falciparum Malaria. Clin Infect Dis. 2019. PMID: 30753363. doi:10.1093/cid/ciz038
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。